By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of common stock raising net proceeds of approximately $32.1 million, the firm said today.

The Northbrook, Ill.-based molecular diagnostics developer sold 15,686,000 shares of common stock at a price of $2.20 per share. Included in that share total is 2,046,000 shares issued to cover an over-allotment option.

Nanosphere said that it would use the funds for general corporate purposes and working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.